Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01980797 · ClinicalTrials.gov registry record
International Bicuspid Aortic Valve Consortium (BAVCon)
A clinical trial of Bicuspid Aortic Valve Disease and Thoracic Aortic Disease in Patients With a Bicuspid Aortic Valve, sponsored by Boston University.
- Active
- Registry status
- 10,000
- Enrollment target
- 12
- Study locations
NCT01980797 is a study of Bicuspid Aortic Valve Disease and Thoracic Aortic Disease in Patients With a Bicuspid Aortic Valve that is active but no longer recruiting, run by Boston University. The registered enrollment target is 10,000 participants. The trial reports 12 study locations across 7 states.
The verdict
NCT01980797, a study of Bicuspid Aortic Valve Disease and Thoracic Aortic Disease in Patients With a Bicuspid Aortic Valve, is active but no longer recruiting, sponsored by Boston University.
- ACTIVE NOT RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 12
- Study locations
Study Summary
Bicuspid aortic valve (BAV) disease is the most frequent congenital cardiac malformation, occurring in 0.5-1.2% of the US population. In young adults, it is generally a benign abnormality; but in older adults it is associated with thoracic aortic aneurysm or dissection in 20-30% of those with BAV. BAV is strongly associated with early development of aortic valve calcification or incompetence in \>50% of BAV patients, and accounts for \~40% of the \>30,000 aortic valve replacements (AVR) performed in the US each year. Yet, we know little of the etiology, cellular events and modifiers of progression of BAV to calcific aortic valve disease and we still do not understand the genetic cause(s) of BAV despite evidence for its high heritability. The Specific Aims of this study are: 1. To identify the genetic causes of bicuspid aortic valve disease and its associated thoracic aortic disease. 2. To identify potential pathways to predict the clinical course of BAV disease and for treating human BAV disease. To achieve these aims, we have created the International Bicuspid Aortic Valve Consortium (BAVCon), a consortium of institutions with cohorts of BAV patients and the expertise to fulfill the performance of these aims.
Conditions Studied
Study Locations (12)
Other
- Monaldi Hospital - Naples
- Second University of Naples - Naples
- University of Salerno - Salerno
- Hospital Vall d'Hebron - Barcelona
- University of Oxford - Oxford
Massachusetts
- Tufts Medical Center - Boston
- Boston Medical Center - Boston
Michigan
- University of Michigan - Ann Arbor
Minnesota
- Mayo Clinic - Rochester
Texas
- University of Texas Health Science Center at Houston - Houston
Quebec
- Laval University - Québec
Milan
- Istituto Policlinico San Donato - San Donato Milanese
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2013-11 |
| Est. Completion | 2028-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01980797
The ClinicalTrials.gov registry entry for NCT01980797 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Bicuspid Aortic Valve Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01980797 reports 12 study locations spanning 7 distinct geographic areas - top geographies include Other, Massachusetts, Michigan.
Frequently Asked Questions
What is clinical trial NCT01980797 about?
NCT01980797 is a clinical study titled "International Bicuspid Aortic Valve Consortium (BAVCon)". Bicuspid aortic valve (BAV) disease is the most frequent congenital cardiac malformation, occurring in 0.5-1.2% of the US population. In young adults, it is generally a benign abnormality; but in older adults it is associated with thoracic aortic aneurysm or dissection in 20-30% of those with BAV. B...
What is the current status of trial NCT01980797?
This trial is currently active not recruiting. The enrollment target is 10,000 participants. The study started on 2013-11. Estimated completion is 2028-11.
What conditions does trial NCT01980797 study?
This clinical trial studies the following conditions: Bicuspid Aortic Valve Disease, Thoracic Aortic Disease in Patients With a Bicuspid Aortic Valve.
Who is sponsoring clinical trial NCT01980797?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01980797 being conducted?
This trial has 12 study locations across Massachusetts, Michigan, Minnesota, Texas, Quebec. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Bicuspid Aortic Valve Disease
All registered trials for this condition
Thoracic Aortic Disease in Patients With a Bicuspid Aortic Valve
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.